Keywords: new, nda, submissions, takeda, tap, japanese, drug

New NDA submissions for Takeda and TAP

Article | 14 January 2008

Print This

Japanese drug major Takeda has submitted a New Drug Application to the US Food and Drug Administration for alogliptin (SYR-322), ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in